Categories Earnings, Health Care

AbbVie’s Q4 results beat expectations

AbbVie (NYSE: ABBV) topped revenue and earnings expectations for the fourth quarter of 2019, allowing the stock to gain over 3% in premarket hours on Friday.

Net revenues of $8.70 billion was up 4.8% compared to the same period a year ago and ahead of consensus estimates of $8.69 billion. On an operational basis, revenues grew 5.3%.

AbbVie tops Q4 2019 revenue and earnings estimates

HUMIRA revenues in international markets were negatively impacted by biosimilar competition during the quarter and absent this impact, net revenues rose 11% operationally.

On a GAAP basis, the company reported net earnings of $2.8 billion, or $1.88 per share, compared to a net loss of $1.8 billion, or $1.23 per share, last year. Adjusted EPS totaled $2.21, beating forecasts of $2.19.   

Global HUMIRA revenues remained unchanged from the prior-year period. HUMIRA revenues increased 9.8% in the US but declined 27.3% internationally due to biosimilar competition. IMBRUVICA revenues improved almost 29% while revenues from the hematologic oncology portfolio grew 37%.

Also read: AbbVie Q4 2019 Earnings Preview

For the full year of 2020, the company expects GAAP EPS to be $7.66-7.76, representing growth of 46% at the midpoint. Adjusted EPS is estimated to be $9.61-9.71, reflecting growth of 8.1% at the midpoint. Revenue is expected to grow at least 8% operationally.  

AbbVie and Allergan have agreed to divest brazikumab and Zenpep as part of the regulatory approval process related to their proposed acquisition agreement. Brazikumab will be acquired by AstraZeneca while Nestle will take over Zenpep. The divestitures are subject to various approvals and closing conditions. Abbvie expects to complete the acquisition of Allergan in the first quarter of 2020.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Earnings Preview: Autodesk (ADSK) looks set to deliver another strong quarter

Autodesk, Inc. (NASDAQ: ADSK) has constantly diversified its business over the years, distributing across multiple industries and geographies. Those initiatives have enabled the company to better prepare itself for the

What to look for when Hormel Foods (HRL) reports Q1 2024 earnings

Shares of Hormel Foods Corporation (NYSE: HRL) stayed red on Monday. The stock has dropped 5% over the past three months. The branded food company is slated to report its

Domino’s Pizza (DPZ) Q4 2023 Earnings: Key financials and quarterly highlights

Domino's Pizza, Inc. (NYSE: DPZ) reported fourth quarter 2023 earnings results today. Total revenues rose to $1.40 billion from $1.39 billion in the same period last year. Net income was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top